title: Prolonged continuous infusion of low-dose rIL-2.
authors.forename: R A
authors.initials: RA
authors.lastname: Janssen
authors.forename: J
authors.initials: J
authors.lastname: Buter
authors.forename: T H
authors.initials: TH
authors.lastname: The
authors.forename: N H
authors.initials: NH
authors.lastname: Mulder
authors.forename: L
authors.initials: L
authors.lastname: de Leij
mesh_terms: D002292:Carcinoma, Renal Cell / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008545:Melanoma / Q000276:immunology*; D011994:Recombinant Proteins / Q000008:administration & dosage; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins